KR101203118B1 - 18-원자 거대고리들 및 그 유사체들 - Google Patents

18-원자 거대고리들 및 그 유사체들 Download PDF

Info

Publication number
KR101203118B1
KR101203118B1 KR1020077019982A KR20077019982A KR101203118B1 KR 101203118 B1 KR101203118 B1 KR 101203118B1 KR 1020077019982 A KR1020077019982 A KR 1020077019982A KR 20077019982 A KR20077019982 A KR 20077019982A KR 101203118 B1 KR101203118 B1 KR 101203118B1
Authority
KR
South Korea
Prior art keywords
delete delete
tiacumicin
compound
opt
antibiotic
Prior art date
Application number
KR1020077019982A
Other languages
English (en)
Korean (ko)
Other versions
KR20070110504A (ko
Inventor
유-콩 슈
찬-고 황
유-훙 치우
알렉스 로메로
파라 바바카니
파멜라 시어즈
프랭클린 오쿠무
Original Assignee
옵티머 파마슈티칼즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 옵티머 파마슈티칼즈, 인코포레이티드 filed Critical 옵티머 파마슈티칼즈, 인코포레이티드
Publication of KR20070110504A publication Critical patent/KR20070110504A/ko
Application granted granted Critical
Publication of KR101203118B1 publication Critical patent/KR101203118B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020077019982A 2005-01-31 2005-01-31 18-원자 거대고리들 및 그 유사체들 KR101203118B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/002887 WO2006085838A1 (en) 2005-01-31 2005-01-31 18-membered macrocycles and analogs thereof

Publications (2)

Publication Number Publication Date
KR20070110504A KR20070110504A (ko) 2007-11-19
KR101203118B1 true KR101203118B1 (ko) 2012-11-20

Family

ID=36793325

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077019982A KR101203118B1 (ko) 2005-01-31 2005-01-31 18-원자 거대고리들 및 그 유사체들

Country Status (10)

Country Link
EP (1) EP1848273A4 (zh)
JP (1) JP5166040B2 (zh)
KR (1) KR101203118B1 (zh)
CN (2) CN101128114B (zh)
AU (1) AU2005327308B2 (zh)
BR (1) BRPI0519890A2 (zh)
CA (1) CA2596387C (zh)
MX (2) MX2007009196A (zh)
TW (1) TWI306097B (zh)
WO (1) WO2006085838A1 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906489B2 (en) 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
US7378508B2 (en) * 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
EP1940417A4 (en) * 2005-10-21 2010-07-07 Optimer Pharmaceuticals Inc METHOD FOR TREATING DIARRHOE IN CONNECTION WITH CLOSTRIDIUM DIFFICILE
TWI482772B (zh) * 2006-08-21 2015-05-01 Astrazeneca Ab 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物
US20080176927A1 (en) * 2007-01-19 2008-07-24 Optimer Pharmaceuticals, Inc. Compositions of stable tiacumicins
ZA200905337B (en) * 2007-01-22 2010-10-27 Optimer Pharmaceuticals Inc Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
AU2012244278C1 (en) * 2007-01-22 2014-11-06 Merck Sharp & Dohme Llc Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
AU2012211968A1 (en) * 2011-02-04 2013-08-29 Optimer Pharmaceuticals, Inc. Treatment of bacterial infections
US8722863B2 (en) 2012-05-10 2014-05-13 Teva Pharmaceutical Works Ltd. Solid state forms of fidaxomycin and processes for preparation thereof
JP2015516438A (ja) * 2012-05-10 2015-06-11 テヴァ・ファーマシューティカル・ワークス・リミテッド フィダキソマイシンの固体状形態およびその調製方法
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
CN103275152B (zh) * 2013-05-29 2015-11-18 华北制药集团新药研究开发有限责任公司 一种高纯度非达霉素的制备方法
ES2668351T3 (es) * 2014-03-18 2018-05-17 Xellia Pharmaceuticals Aps Nuevos polimorfos y nuevos estados sólidos de tiacumicina B
CN103897003B (zh) * 2014-03-28 2016-07-06 华北制药集团新药研究开发有限责任公司 非达霉素晶型ii及其制备方法
EP3139932B1 (en) 2014-05-09 2018-08-01 Astellas Pharma Europe Ltd. Treatment regimen for tiacumicin compound
AU2016289307A1 (en) 2015-07-03 2018-01-18 Astellas Pharma Europe Ltd. Novel dosage regimen tiacumicin compound
CN105237599B (zh) * 2015-10-09 2018-10-02 华北制药集团新药研究开发有限责任公司 闰年霉素a4晶体及其制备方法
CN110183502A (zh) * 2019-05-28 2019-08-30 杭州华东医药集团新药研究院有限公司 一种非达霉素杂质及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4918174A (en) * 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US5583115A (en) * 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
US5767096A (en) * 1996-07-12 1998-06-16 Abbott Laboratories Bromotiacumicin compounds
ES2527052T3 (es) * 2002-07-29 2015-01-20 Optimer Pharmaceuticals, Inc. Producción de tiacumicina
MX344601B (es) * 2004-05-14 2016-12-20 Merck Sharp & Dohme Tratamiento de enfermedades asociadas con el uso de antibioticos.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Antimicrobial Agents and Chemotherapy. 48(11), pp.4430-4434(2004.11.)*
The Journal of Antibiotics. 41(3), pp.308-315(1988.03.)*

Also Published As

Publication number Publication date
CN101128114B (zh) 2012-03-28
CN101128114A (zh) 2008-02-20
TWI306097B (en) 2009-02-11
MX2007009196A (es) 2009-02-25
JP5166040B2 (ja) 2013-03-21
BRPI0519890A2 (pt) 2009-03-31
CN102614207A (zh) 2012-08-01
TW200626585A (en) 2006-08-01
CN102614207B (zh) 2016-01-13
CA2596387C (en) 2012-11-20
KR20070110504A (ko) 2007-11-19
WO2006085838A1 (en) 2006-08-17
MX340742B (es) 2016-07-21
AU2005327308B2 (en) 2011-11-10
EP1848273A4 (en) 2010-02-24
JP2008528582A (ja) 2008-07-31
AU2005327308A1 (en) 2006-08-17
CA2596387A1 (en) 2006-08-17
EP1848273A1 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
KR101203118B1 (ko) 18-원자 거대고리들 및 그 유사체들
US8586551B2 (en) 18-membered macrocycles and analogs thereof
JP5764168B2 (ja) 大環状多形、そのような多形を含む組成物、ならびにその使用方法および製造方法
JP6101010B2 (ja) 抗生物質の使用に関連する疾患の治療
JP5843344B2 (ja) 大環状抗生物質化合物並びにその製造及び使用の方法
CN103880930B (zh) 万古霉素类衍生物及其制备方法和药用用途
AU2012200784B2 (en) 18-membered macrocycles and analogs thereof
Ullah et al. Bioavailability of antibiotics and their toxicity
JP5825217B2 (ja) １８員大環状化合物及びその類似化合物
CN106317206A (zh) 去甲万古霉素类二聚体衍生物及其制备方法和药用用途

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20150930

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20161028

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20170929

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20180928

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20190924

Year of fee payment: 8